MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    A cross-sectional study of sensor-based gait analysis in atypical Parkinsonian disorders

    C. Raccagni, H. Gassner, S. Eschlböck, S. Bösch, F. Krismer, M. Nocker, K. Seppi, W. Poewe, J. Klucken, G. Wenning (Innsbruck, Austria)

    Objective: Primary objective was to identify quantitative markers of gait impairment in patients with idiopathic Parkinson's disease (IPD), atypical Parkinsonian disorders (APD) and healthy controls…
  • 2016 International Congress

    Loss of FBXO7 (PARK15) leads to disturbances in proteasomal function and models parkinsonism-like and pyramidal symptoms in mice

    S. Vingill, D. Brockelt, N. Schwedhelm-Domeyer, L. Tatenhorst, S. Goebbels, P. Lingor, K.A. Nave, J. Stegmueller (Goettingen, Germany)

    Objective: To model Parkinsonian-pyramidal syndrome (PARK15) in mice and investigate the impact of loss of F-box only protein 7 (FBXO7) in neurons on proteasomal activity.…
  • 2016 International Congress

    Greater incidence of depressive symptoms in atypical parkinsonism: Importance of early screening

    L. Almeida, B. Ahmed, R. Walz, S. De Jesus, A. Patterson, D. Martinez-Ramirez, D. Vaillancourt, D. Bowers, H. Ward, M.S. Okun, M. Armstrong, N. McFarland (Gainesville, FL, USA)

    Objective: To evaluate the incidence of depressive symptoms in Parkinsonian patients in a large cohort followed at a tertiary movement disorders center. Background: Despite relative…
  • 2016 International Congress

    Hyposmia as a predictor of non-motor symptom in patients with de novo Parkinson’s disease

    M. Sanoeva, N. Mansurova, A. Prokhorova (Bukhara, Uzbekistan)

    Objective: To evaluate hyposmia as a predictor of non-motor features in patients with early Parkinson's disease (PD). Background: Hyposmia is quite a common finding in…
  • 2016 International Congress

    The heterogeneity of fatigue in different stages of Parkinson’s disease

    M.R. Nodel, N.N. Yakhno (Moscow, Russia)

    Objective: To identify factors associated with fatigue in different stages of PD. Background: Fatigue is an important contributor to poor quality of life. However, it…
  • 2016 International Congress

    P100 latency of pattern reversal visual evoked potential and visual hallucination in Parkinson’s disease

    M. Kohsaka, T. Oeda, A. Umemura, S. Tomita, K. Park, K. Yamamoto, H. Sugiyama, H. Sawada (Kyoto, Japan)

    Objective: To investigate whether P100 latency of pattern reversal visual evoked potential (PR-VEP) can predict the development of visual hallucination (VH) in Parkinson's disease (PD).…
  • 2016 International Congress

    Clinical and biological predictors of excessive daytime sleepiness in early Parkinson’s disease

    T. Simuni, J. Long, C. Caspell-Garcia, C.S. Coffey, W. Oertel, S. Lasch, K. Marek, On behalf of the PPMI Sleep Working Group (Chicago, IL, USA)

    Objective: To examine longitudinal change in excessive daytime sleepiness (EDS) and to determine clinical and biological variables that predict new onset EDS in the cohort…
  • 2016 International Congress

    Frequency of non-motor symptoms in Iranian patients with Parkinson’s disease

    M. Salari, O. Mirmosayyeb (Isfahan, Islamic Republic of Iran)

    Objective: To evaluate prevalence of nanometer symptoms in patients with Parkinson's disease. Background: While PD (Parkinson's disease) is diagnosed on the basis of motor symptoms,…
  • 2016 International Congress

    Movement disorders (Parkinson’s disease) in Uzbekistan: Epidemiologic, clinical and therapeutic aspects

    N. Eshakulova, A. Umarov, N. Tuychibaeva, G. Rakhimbaeva, M. Ataniyazov (Tashkent, Uzbekistan)

    Objective: The aim was to determine the epidemiologic, clinical and therapeutic aspects of patients treated for PD. Methods: This was a prospective and cross-sectional study…
  • 2016 International Congress

    Prevalence of Parkinson’s disease in the region of Coquimbo, Chile

    M. Contreras, P. Pizarro, U. Hernandez, C. Gomez, J. Gajardo (La Serena, Chile)

    Objective: To determine the rate of prevalence of PD in the region of Coquimbo, Chile. Background: Parkinson's disease is a common neurodegenerative disease, second after…
  • « Previous Page
  • 1
  • …
  • 329
  • 330
  • 331
  • 332
  • 333
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley